Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-06 Option Award |
2025-02-10 5:40 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Phillips Andrew John Director |
20,491 | $0 | 20,491 (Direct) |
View |
2024-10-04 Option Award |
2024-10-08 7:28 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director |
15,300 | $0 | 15,300 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director |
7,688 | $0 | 7,688 (Direct) |
View |
2024-02-13 Option Award(A) |
2024-02-20 7:35 pm |
N/A 2034-02-13 |
Enliven Therapeutics Inc. | ELVN | Phillips Andrew John Director |
23,364 | $0 | 23,364 (Direct) |
View |
2024-02-13 Option Award |
2024-02-15 9:04 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Phillips Andrew John Director |
16,835 | $0 | 16,835 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:47 pm |
N/A 2033-06-08 |
MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director |
11,297 | $0 | 11,297 (Direct) |
View |
2023-02-23 Option Award |
2023-04-06 8:20 pm |
N/A 2033-02-23 |
Enliven Therapeutics Inc. | ELVN | Phillips Andrew John Director |
27,567 | $0 | 27,567 (Direct) |
View |
2022-04-06 Option Award |
2022-05-05 5:45 pm |
N/A 2032-04-06 |
MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director |
45,000 | $0 | 45,000 (Direct) |
View |